178 related articles for article (PubMed ID: 38130028)
1. PIVKA-II combined with tumor burden score to predict long-term outcomes of AFP-negative hepatocellular carcinoma patients after liver resection.
Qiu ZC; Wu YW; Qi WL; Li C
Cancer Med; 2023 Dec; 13(1):. PubMed ID: 38130028
[TBL] [Abstract][Full Text] [Related]
2. Tumor burden score-AFP-albumin-bilirubin grade score predicts the survival of patients with hepatocellular carcinoma after liver resection.
Qiu ZC; Li C; Zhang Y; Xie F; Yu Y; Leng SS; Chen TH; Wen TF
Langenbecks Arch Surg; 2023 Jun; 408(1):250. PubMed ID: 37382724
[TBL] [Abstract][Full Text] [Related]
3. Radiographic tumor burden score is useful for stratifying the overall survival of hepatocellular carcinoma patients undergoing resection at different Barcelona Clinic Liver Cancer stages.
Li WF; Liu YW; Wang CC; Yong CC; Lin CC; Yen YH
Langenbecks Arch Surg; 2023 May; 408(1):169. PubMed ID: 37121930
[TBL] [Abstract][Full Text] [Related]
4. Prothrombin induced by vitamin K Absence-II versus alpha-fetoprotein in detection of both resectable hepatocellular carcinoma and early recurrence after curative liver resection: A retrospective cohort study.
Wang MD; Sun LY; Qian GJ; Li C; Gu LH; Yao LQ; Diao YK; Pawlik TM; Lau WY; Huang DS; Shen F; Yang T
Int J Surg; 2022 Sep; 105():106843. PubMed ID: 35995351
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal surveillance of three biomarkers to predict recurrence of hepatocellular carcinoma after radical resection.
Tong JS; Lu CD; Lu CJ; Zheng S; Mao SQ
Eur J Gastroenterol Hepatol; 2023 Oct; 35(10):1178-1185. PubMed ID: 37577836
[TBL] [Abstract][Full Text] [Related]
6. Estimating postsurgical outcomes of patients with a single hepatocellular carcinoma using gadoxetic acid-enhanced MRI: risk scoring system development and validation.
Park SH; Kim B; Kim S; Park S; Park YH; Shin SK; Sung PS; Choi JI
Eur Radiol; 2023 May; 33(5):3566-3579. PubMed ID: 36933020
[TBL] [Abstract][Full Text] [Related]
7. Survival outcomes of hepatectomy for stage B Hepatocellular carcinoma in the BCLC classification.
Kamiyama T; Orimo T; Wakayama K; Shimada S; Nagatsu A; Yokoo H; Kamachi H; Yamashita K; Shimamura T; Taketomi A
World J Surg Oncol; 2017 Aug; 15(1):156. PubMed ID: 28830473
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of gamma-glutamyltransferase/aspartate aminotransferase ratio, protein induced by vitamin K absence or antagonist II, and alpha-fetoprotein in hepatitis B virus-related hepatocellular carcinoma.
Wang Q; Chen Q; Zhang X; Lu XL; Du Q; Zhu T; Zhang GY; Wang DS; Fan QM
World J Gastroenterol; 2019 Sep; 25(36):5515-5529. PubMed ID: 31576097
[TBL] [Abstract][Full Text] [Related]
9. The prognostic significance of inflammation-immunity-nutrition score on postoperative survival and recurrence in hepatocellular carcinoma patients.
Liang Y; Zhang Z; Zhong D; Lai C; Dai Z; Zou H; Feng T; Shang J; Shi Y; Huang X
Front Oncol; 2022; 12():913731. PubMed ID: 36016629
[TBL] [Abstract][Full Text] [Related]
10. Alpha-Fetoprotein Combined with Radiographic Tumor Burden Score to Predict Overall Survival after Liver Resection in Hepatocellular Carcinoma.
Yen YH; Liu YW; Li WF; Wang CC; Yong CC; Lin CC; Lin CY
Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831544
[TBL] [Abstract][Full Text] [Related]
11. A new model based inflammatory index and tumor burden score (TBS) to predict the recurrence of hepatocellular carcinoma (HCC) after liver resection.
Wang J; Chen Z; Wang L; Feng S; Qiu Q; Chen D; Li N; Xiao Y
Sci Rep; 2022 May; 12(1):8670. PubMed ID: 35606395
[TBL] [Abstract][Full Text] [Related]
12. Effect of PIVKA-II and AFP secretion status on early recurrence of hepatocellular carcinoma after open and laparoscopic surgery.
Cai Y; Xie K; Adeeb Alhmoud MN; Lan T; Wan H; Hu D; Lan L; Liu C; Wu H
Cancer Med; 2023 Sep; 12(17):17866-17877. PubMed ID: 37596739
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of serum PIVKA-II levels for BCLC early hepatocellular carcinoma and correlation with HBV DNA.
Wu J; Xiang Z; Bai L; He L; Tan L; Hu M; Ren Y
Cancer Biomark; 2018; 23(2):235-242. PubMed ID: 30103302
[TBL] [Abstract][Full Text] [Related]
14. Significance of PIVKA-II levels for predicting microvascular invasion and tumor cell proliferation in Chinese patients with hepatitis B virus-associated hepatocellular carcinoma.
Ma XL; Zhu J; Wu J; Tian L; Gao YY; Zhang CY; Zhou Y; Dai Q; Wang BL; Pan BS; Zhou J; Fan J; Yang XR; Guo W
Oncol Lett; 2018 Jun; 15(6):8396-8404. PubMed ID: 29805574
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic value of prothrombin induced by the absence of vitamin K or antagonist-II (PIVKA-II) for early stage HBV related hepatocellular carcinoma.
Wang X; Zhang W; Liu Y; Gong W; Sun P; Kong X; Yang M; Wang Z
Infect Agent Cancer; 2017; 12():47. PubMed ID: 28852419
[TBL] [Abstract][Full Text] [Related]
16. The Role of PIVKA-II as a Predictor of Early Hepatocellular Carcinoma Recurrence-Free Survival after Liver Transplantation in a Low Alpha-Fetoprotein Population.
Devillers MJC; Pluimers JKF; van Hooff MC; Doukas M; Polak WG; de Man RA; Sonneveld MJ; Boonstra A; den Hoed CM
Cancers (Basel); 2023 Dec; 16(1):. PubMed ID: 38201435
[TBL] [Abstract][Full Text] [Related]
17. A scoring model combining serum alpha-fetoprotein and tumor size and number predicts prognosis in hepatitis B virus-related hepatocellular carcinoma patients after curative hepatectomy.
Wei B; Chen JS; Yang SL; Chen GG; He H
Transl Cancer Res; 2019 Aug; 8(4):1438-1448. PubMed ID: 35116886
[TBL] [Abstract][Full Text] [Related]
18. Tumor Burden Score and Serum Alpha-fetoprotein Subclassify Intermediate-Stage Hepatocellular Carcinoma.
Lima HA; Endo Y; Alaimo L; Moazzam Z; Munir MM; Shaikh C; Resende V; Guglielmi A; Marques HP; Cauchy F; Lam V; Poultsides GA; Popescu I; Alexandrescu S; Martel G; Hugh T; Endo I; Kitago M; Shen F; Pawlik TM
J Gastrointest Surg; 2022 Dec; 26(12):2512-2521. PubMed ID: 36171471
[TBL] [Abstract][Full Text] [Related]
19. Validation of an alpha-fetoprotein model to predict recurrence after liver resection for hepatocellular carcinoma.
Li WF; Yen YH; Liu YW; Wang CC; Yong CC; Lin CC; Cheng YF; Wang JH
Updates Surg; 2022 Aug; 74(4):1345-1352. PubMed ID: 34374920
[TBL] [Abstract][Full Text] [Related]
20. Nomograms Incorporating the CNLC Staging System Predict the Outcome of Hepatocellular Carcinoma After Curative Resection.
Liao R; Wei XF; Che P; Yin KL; Liu L
Front Oncol; 2021; 11():755920. PubMed ID: 35127471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
